Literature DB >> 34306407

The Effect of 5A nursing intervention on living quality and self-care efficacy of patients undergoing chemotherapy after hepatocellular carcinoma surgery.

Xuejuan Zhang1, Min Lai2, Donghan Wu1, Pidan Luo1, Shuixi Fu3.   

Abstract

OBJECTIVES: This paper explored and analyzed the effect of 5A nursing intervention on living quality and self-care efficacy of patients undergoing postoperative chemotherapy after hepatocellular carcinoma surgery.
METHODS: A total of 97 patients with hepatocellular carcinoma hospitalized from March 2017 to June 2019 were chosen as subjects and separated to the control group (n=47) and observation group (n=50) based on the admission time. The control-group received a conventional nursing care mode, and the observation-group was given the 5A nursing care mode in addition to the conventional care mode in the control group. Self-care efficacy, SF-36 quality of life, cancer-related fatigue degree and satisfaction with nursing work of patients pre- and post-intervention were compared between the two groups.
RESULTS: The self-care efficacy of the two groups post-intervention was critically higher than during pre-intervention (P<0.05), and the index of the observation group was significantly higher than that of the control group (P<0.05). The scores in each dimension of life quality in both groups after intervention were remarkably higher than those for pre-intervention (P<0.05), and the index in observation group was notably higher than that in the control group (P<0.05). Cancer-related fatigue degree of the two groups of patients during post-intervention was critically higher than those in pre-intervention (P<0.05), while during post-intervention, the index in control group was notably higher than in observation group (P<0.05). The satisfaction degree of nursing skills, service attitude, health training and hospital condition in the observation group were significantly higher than those in the control group (P<0.05).
CONCLUSION: The model of 5A nursing intervention can ameliorate the self-care efficacy and living quality of patients undergoing chemotherapy after hepatocellular carcinoma surgery. The intervention can also help alleviate cancer-related fatigue during treatment, and improve the satisfaction degree of patients with nursing care, which is worthy of clinical promotion and application. AJTR
Copyright © 2021.

Entities:  

Keywords:  5A nursing intervention; postoperative chemotherapy after hepatocellular carcinoma; quality of life; self-care efficacy

Year:  2021        PMID: 34306407      PMCID: PMC8290751     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

1.  Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Authors:  Farhad Islami; Kimberly D Miller; Rebecca L Siegel; Stacey A Fedewa; Elizabeth M Ward; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-06-06       Impact factor: 508.702

2.  [Five-Year Local Control by Stereotactic Body Radiation Therapy(SBRT)for Liver Metastasis from Colorectal Cancer-A Case Report].

Authors:  Mitsunori Ushigome; Kimihiko Funahashi; Kimihiko Yoshida; Takamaru Koda; Yasuyuki Miura; Satoru Kagami; Tomoaki Kaneko; Yasuo Nagashima; Atsuro Terahara
Journal:  Gan To Kagaku Ryoho       Date:  2019-12

3.  Prediagnostic Level of Dietary and Urinary Isoflavonoids in Relation to Risk of Liver Cancer in Shanghai, China.

Authors:  Wei Zhang; Jing Wang; Jing Gao; Hong-Lan Li; Li-Hua Han; Qing Lan; Nathaniel Rothman; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-06       Impact factor: 4.254

Review 4.  The gut microbiome and liver cancer: mechanisms and clinical translation.

Authors:  Le-Xing Yu; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-05       Impact factor: 46.802

Review 5.  Chimeric antigen receptor-engineered T-cell therapy for liver cancer.

Authors:  Yang Chen; Chang-Yong E; Zhi-Wen Gong; Shui Liu; Zhen-Xiao Wang; Yong-Sheng Yang; Xue-Wen Zhang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2018-05-24

6.  Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study.

Authors:  Adomas Bunevicius
Journal:  Health Qual Life Outcomes       Date:  2017-05-04       Impact factor: 3.186

Review 7.  Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.

Authors:  Qi Zhang; Yu Lou; Xue-Li Bai; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

Review 8.  Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies.

Authors:  Hedong Han; Tianyi Zhang; Zhichao Jin; Honglei Guo; Xin Wei; Yuzhou Liu; Qi Chen; Jia He
Journal:  Oncotarget       Date:  2017-07-25

9.  Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.

Authors:  Srinivas Pittala; Yakov Krelin; Varda Shoshan-Barmatz
Journal:  Neoplasia       Date:  2018-05-07       Impact factor: 5.715

10.  Risk factors for developing liver cancer in people with and without liver disease.

Authors:  Jae Kyung Suh; Jayoun Lee; Jeong-Hoon Lee; Sangjin Shin; Ha Jin Tchoe; Jin-Won Kwon
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.